Using Hypnosis to Help Children Undergoing a Difficult Medical Procedure

This study has been completed.

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00226850

Purpose

This study examined whether a hypnosis intervention, compared to standard care, could help reduce distress and pain for children undergoing an invasive medical procedure.

Condition	Intervention	Phase
Voiding Cystourethrogram (VCUG)	Behavioral: hypnosis	Phase III

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Randomized, Open Label, Active Control, Parallel Assignment

Eligibility

Ages Eligible for Study:	5 Years to 18 Years
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

The child: (1) was scheduled for an upcoming VCUG ; (2) must have undergone at least one previous VCUG; (3) was at least 4 years of age at the time of the previous VCUG; (4) experienced distress during the previous VCUG; and (5) both child and participating parent were English speaking.

Exclusion Criteria:

Not meeting any of the above criteria.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00226850

Locations

United States, California
Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine
Stanford, California, United States, 94305-5718
Lucile Packard Children's Hospital
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Investigators

Study Director:	Lisa D. Butler, Ph.D.	Stanford University
Principal Investigator:	David Spiegel, M.D.	Stanford University
Principal Investigator:	Linda D Shortliffe, M.D.	Stanford University

More Information

Publications of Results:

Butler LD, Symons BK, Henderson SL, Shortliffe LD, Spiegel D. Hypnosis reduces distress and duration of an invasive medical procedure for children. Pediatrics. 2005 Jan;115(1):e77-85.

Study ID Numbers:	1HUK610
Study First Received:	September 12, 2005
Last Updated:	September 23, 2005
ClinicalTrials.gov Identifier:	NCT00226850
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on January 16, 2009